- Home
- IMMX vs TPIC Comparison
IMMX vs TPIC Comparison
Compare IMMX & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- TPIC
- Stock Information
- Founded
- IMMX 2014
- TPIC 1968
- Country
- IMMX United States
- TPIC United States
- Employees
- IMMX N/A
- TPIC N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- TPIC Industrial Machinery/Components
- Sector
- IMMX Health Care
- TPIC Industrials
- Exchange
- IMMX Nasdaq
- TPIC Nasdaq
- Market Cap
- IMMX 61.1M
- TPIC 58.4M
- IPO Year
- IMMX 2021
- TPIC 2016
- Fundamental
- Price
- IMMX $2.65
- TPIC $0.84
- Analyst Decision
- IMMX Strong Buy
- TPIC Hold
- Analyst Count
- IMMX 1
- TPIC 7
- Target Price
- IMMX $7.00
- TPIC $1.68
- AVG Volume (30 Days)
- IMMX 137.1K
- TPIC 865.3K
- Earning Date
- IMMX 08-11-2025
- TPIC 08-07-2025
- Dividend Yield
- IMMX N/A
- TPIC N/A
- EPS Growth
- IMMX N/A
- TPIC N/A
- EPS
- IMMX N/A
- TPIC N/A
- Revenue
- IMMX N/A
- TPIC $1,373,242,000.00
- Revenue This Year
- IMMX N/A
- TPIC $10.66
- Revenue Next Year
- IMMX N/A
- TPIC $6.52
- P/E Ratio
- IMMX N/A
- TPIC N/A
- Revenue Growth
- IMMX N/A
- TPIC 3.05
- 52 Week Low
- IMMX $1.26
- TPIC $0.64
- 52 Week High
- IMMX $3.00
- TPIC $5.26
- Technical
- Relative Strength Index (RSI)
- IMMX 61.44
- TPIC 37.37
- Support Level
- IMMX $2.16
- TPIC $0.86
- Resistance Level
- IMMX $2.80
- TPIC $1.01
- Average True Range (ATR)
- IMMX 0.17
- TPIC 0.10
- MACD
- IMMX 0.04
- TPIC -0.02
- Stochastic Oscillator
- IMMX 80.00
- TPIC 6.43
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.